Skip to main content
GENESIS IBRC INDIA LIMITED logo

GENESIS IBRC INDIA LIMITED — Investor Relations & Filings

Ticker · 514336 ISIN · INE194N01016 BSE.NS Manufacturing
Open in API
Filings indexed 311 across all filing types
Latest filing 2026-01-22 Board/Management Inform…
Country IN India
Listing BSE.NS 514336

About GENESIS IBRC INDIA LIMITED

https://genesisiil.com/

Genesis IBRC India Limited is a biotechnology-driven enterprise focused on the research, development, and commercialization of advanced biological solutions. The company specializes in the production of high-quality probiotics and industrial enzymes tailored for diverse applications. Its product portfolio serves critical sectors including aquaculture, poultry, animal husbandry, and human nutrition, providing microbial formulations designed to enhance growth, immunity, and overall health. In the industrial segment, the company develops enzymatic solutions for the textile, leather, and paper processing sectors to improve efficiency and environmental sustainability. Genesis IBRC emphasizes innovation through its dedicated research facilities, focusing on strain selection and fermentation technology to deliver standardized and effective biochemical products. The company aims to provide science-based alternatives to traditional chemical processes across global markets.

Recent filings

Filing Released Lang Actions
Genesis Ibrc India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve As agenda mentioned in the ....
Board/Management Information Classification · 95% confidence The document is an official notice addressed to the Bombay Stock Exchange regarding an upcoming Board Meeting scheduled for January 28, 2026. It lists agenda items such as alteration of the Memorandum of Association, increase in authorized share capital, raising funds through equity shares or securities, appointment of valuer, and other procedural matters related to corporate governance and capital raising. The document is a notification of a board meeting and does not contain financial statements, audit information, or detailed financial results. It is not a report or a presentation but an announcement of a board meeting pursuant to SEBI regulations. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or meetings of the company's board of directors or senior management.
2026-01-22 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for V Varalakshmi
Major Shareholding Notification Classification · 95% confidence The document is a disclosure filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It details the sale of shares through an inter-se transfer by way of gift within the Promoter/Promoter Group, including specifics about shareholding before and after the transaction. The document is addressed to the Bombay Stock Exchange and is a formal notification of a shareholding change due to a transfer among promoters. This fits the definition of a Major Shareholding Notification (MRQ), which involves notification of changes in significant share ownership levels. The document is not a full financial report, earnings release, or any other type of report but a regulatory disclosure about shareholding changes. Therefore, the correct classification is MRQ with high confidence.
2026-01-21 English
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Padmanaban Krishnamoorthy
Major Shareholding Notification Classification · 100% confidence The document is an official communication addressed to the Board of Directors and Compliance Officer of GENESIS IBRC INDIA LIMITED. It references SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, specifically Regulation 10(6), which pertains to disclosures related to acquisitions of shares by promoters or promoter groups. The content details an inter-se transfer of shares by way of gift between immediate relatives within the promoter group, including shareholding percentages before and after the transaction. The document is a formal notification of a change in substantial shareholding and complies with regulatory disclosure requirements under SEBI takeover regulations. There is no indication of financial performance data, earnings, or management discussion, nor is it a report publication announcement or certification. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds.
2026-01-21 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Padmanaban Krishnamoorthy
Major Shareholding Notification Classification · 100% confidence The document is a disclosure submitted to the Bombay Stock Exchange under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It details the acquisition of shares through an inter-se transfer by way of gift within the promoter/promoter group, including specifics on shareholding percentages before and after the transaction. The document is a formal notification of a change in substantial shareholding, not a financial report, earnings release, or management discussion. It fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document length and content confirm it is not a brief announcement or a report publication notice but a substantive regulatory filing about share acquisition.
2026-01-21 English
Compliance certificate
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming compliance for the quarter ended 31st December 2025. It is a compliance certificate related to securities dematerialization/rematerialization and is addressed to the stock exchange. The document is short (2337 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance certificates and miscellaneous regulatory announcements that do not fit other specific categories.
2026-01-20 English
Change in name of the Company to CCME Global Limited or any other name approved by MCA, subject to shareholders and other authorities approval. We will make application with the stock exchange ....
Regulatory Filings
2026-01-19 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.